Long-term results of Nivolumab + Cabozantinib in RCC

Published Date: 08 Mar 2023

The combination of first-line nivolumab and cabozantinib continues to outperform sunitinib in the treatment of patients with advanced renal cell carcinoma (RCC).

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances

2.

GLP-1 Receptor antagonists used in a study allay fears about thyroid cancer.

3.

Immune cell homing hydrogel-based platform captures dendritic cells to process mRNA from cancer vaccines

4.

Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.

5.

The September 2018 issue of Medical Bulletin.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot